Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2025-12-24 @ 3:51 PM
NCT ID:
NCT06982092
Eligibility Criteria:
Inclusion Criteria:
* Patients with American Society of Anesthesiologists' (ASA) physical status I or II or III
* Adult patients aging (18-65) years of both sexes. who undergoing deep neuromuscular block with rocuronium.
* Patients Scheduled for elective FISS surgery
Exclusion Criteria:
* Patient's refusal of procedure or participation in the study.
* ASA class IV.
* History of hepatic disease (Child Pugh B or C class).
* History of renal disease.
* Allergy or hypersensitivity to sugammadex or neostigmine.
* History of neuromuscular disease.
* Diaphragmatic palsy, pregnancy, nursing.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06982092
Study Brief:
Protocol Section:
NCT06982092